secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alpha Teknova, Inc. (TKNO)
CIK:        0001850902
Form:       8-K
Filed at:   2022-05-11T23:59:59+00:00
Accession:  0000950170-22-009317
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teknova Q1 revenue $11.1M (+23% YoY); guides FY2022 revenue $45-48M
-------------------------------------------------------------------

- Q1 2022 revenue $11.1M up 23% YoY; Lab Essentials $6.98M, Clinical Solutions $3.81M, Sample Transport $6K.
- Net loss -$5.5M (-$0.20 diluted EPS) vs -$0.7M loss in Q1 2021; Adjusted EBITDA -$4.3M vs break-even.
- Cash position $76.5M; amended credit facility increased from $27M to $57M to fund growth.
- FY2022 revenue guidance of $45-48M (over 30% growth at midpoint); Lab Essentials ~25% growth, Clinical Solutions at least 60%.
- No material Sample Transport revenue expected in 2022; new manufacturing facility expected online by year end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850902/000095017022009317/0000950170-22-009317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850902/000095017022009317/tkno-20220511.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-009317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer